 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos...

Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, JBT SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, JBT PR Newswire NEW YORK, April 9, 2024 NEW YORK, April...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, JBT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, DOMA SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, DOMA PR Newswire NEW YORK, April 5, 2024 NEW YORK, April...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, DOMA

Landos Biopharma (NASDAQ:LABP - Get Free Report)s stock had its "neutral" rating reissued by stock analysts at HC Wainwright in a research note issued to investors on Monday, Benzinga reports...

HC Wainwright Reiterates Neutral Rating for Landos Biopharma (NASDAQ:LABP)

Landos Biopharma (LABP Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from...

Maintaining Hold Rating on Landos Biopharma Amid Acquisition by AbbVie and Limited Upside Potential

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Landos Biopharma just downgraded at H.C. Wainwright, here's why

NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ADTH, LABP, FUSN

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates HRT, FXNC, LABP, KAMN SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates HRT, FXNC, LABP, KAMN PR Newswire NEW YORK, March 28, 2024 NEW YORK, March...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates HRT, FXNC, LABP, KAMN

This week, AbbVie ABBV announced plans to buy Landos Biopharma, while Novo Nordisk NVO offered to acquire Germany-based biotech Cardior Pharmaceuticals. The FDA approved J&J&rsquo;s JNJ and...

Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs

NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DRQ, FUSN, LABP, FXNC

Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of novel, oral, once-daily therapeutics for patients with certain immunology diseases. It offers NX-13, a novel, oral, gut-restricted compound for the treatment of inflammatory bowel disease, which targets the NLRX1 pathway. The firm's preclinical candidates include LABP-73, LABP-66, and LABP-69. The company was founded by Josep Bassaganya-Riera in January 2017 and is headquartered in Blacksburg, VA.

Volume (M)	1.00
52-Wk High	$21.87
52-Wk Low	$2.50

LABP Landos Biopharma Inc

About

Feed

News

Sentiment

Fundamentals